Immuneel
Bangalore, India · $37.9M raised
- Headquarters
- Bangalore
- Employees
- 11–50
- Business Model
- B2C
- Website
- immuneel.com
- Total Funding
- $37.9M
- Last Round
- $10.5M Series BJan 2025
- Rounds
- 4
About
Clinical-stage Indian biotech pioneering CAR-T cell and gene therapies to make cancer treatments affordable in India.
Summary
Immuneel is a Biotech company based in Bangalore, India. It has raised $37.9M in total across 4 rounds, most recently a $10.5M Series B round in Jan 2025. Investors include Rainmatter, Eight Roads Ventures and F-Prime Capital.
Tech & App Stack
5 technologies & apps tracked
Create a free account to track companies, build lists, and unlock premium data like the full tech & app stack.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Funding History
Jan 2025
Sign up to see all 4 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Specialty pharmaceutical company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...